"A new consumer-friendly form ( is now available for making reports to MedWatch, the Food and Drug Administration's (FDA) on-line system for collecting information about serious problems with drugs, medical devices and other FDA-"...
(Generic versions may still be available.)
**Efficacy for this organism was studied in fewer than 10 infections.
DOSAGE AND ADMINISTRATION
The recommended dose in adults and pediatric patients (one year and older) is one or two drops of CHIBROXIN (norfloxacin) Ophthalmic Solution applied topically to the affected eye(s) four times daily for up to seven days. Depending on the severity of the infection, the dosage for the first day of therapy may be one or two drops every two hours during the waking hours.
CHIBROXIN (norfloxacin) Ophthalmic Solution is a clear, colorless to light yellow solution.
No. 3526 CHIBROXIN (norfloxacin) Ophthalmic Solution 0.3% is supplied in a white, opaque, plastic OCUMETER* ophthalmic dispenser with a controlled drop tip as follows:
NDC 0006-3526-03, 5 mL.
Store CHIBROXIN (norfloxacin) Ophthalmic Solution at room temperature, 15°-30°C (59°-86°F). Protect from light.
*Registered trademark of MERCK & CO., INC.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Chibroxin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.